Decoy Therapeutics, Inc. (DCOY)
3.13
+0.02
(+0.64%)
USD |
NASDAQ |
Aug 25, 09:49
Decoy Therapeutics Total Liabilities (Quarterly) : 4.680M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.680M |
| March 31, 2026 | 4.546M |
| December 31, 2025 | 5.168M |
| September 30, 2025 | 1.849M |
| June 30, 2025 | 2.222M |
| March 31, 2025 | 2.278M |
| December 31, 2024 | 1.511M |
| September 30, 2024 | 0.9346M |
| June 30, 2024 | 1.178M |
| March 31, 2024 | 1.234M |
| December 31, 2023 | 1.299M |
| September 30, 2023 | 2.320M |
| June 30, 2023 | 3.642M |
| March 31, 2023 | 4.496M |
| December 31, 2022 | 4.266M |
| September 30, 2022 | 3.110M |
| June 30, 2022 | 2.770M |
| March 31, 2022 | |
| December 31, 2021 | 2.111M |
| September 30, 2021 | 1.612M |
| June 30, 2021 | 1.554M |
| March 31, 2021 | 1.990M |
| December 31, 2020 | 2.773M |
| September 30, 2020 | 2.457M |
| Date | Value |
|---|---|
| June 30, 2020 | 1.707M |
| March 31, 2020 | 2.063M |
| December 31, 2019 | 3.314M |
| September 30, 2019 | 4.721M |
| June 30, 2019 | 1.036M |
| March 31, 2019 | 0.9111M |
| December 31, 2018 | 7.885M |
| September 30, 2018 | 2.888M |
| June 30, 2018 | 3.803M |
| March 31, 2018 | 4.145M |
| December 31, 2017 | 5.887M |
| September 30, 2017 | 5.026M |
| June 30, 2017 | 5.125M |
| March 31, 2017 | 3.278M |
| December 31, 2016 | 3.898M |
| September 30, 2016 | 3.924M |
| June 30, 2016 | 3.413M |
| March 31, 2016 | 3.082M |
| December 31, 2015 | 2.877M |
| September 30, 2015 | 2.762M |
| June 30, 2015 | 2.557M |
| March 31, 2015 | 1.863M |
| December 31, 2014 | 1.119M |
| September 30, 2014 | 0.8033M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Palatin Technologies, Inc. | 2.634M |
| Unicycive Therapeutics, Inc. | 18.76M |
| Nuvectis Pharma, Inc. | 13.29M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.001M |
| Shareholders Equity (Quarterly) | 4.321M |
| Current Ratio | 1.832 |
| Net Debt Paydown Yield | 0.59% |